Efficacy and safety of venlafaxine ER in the treatment of children and adolescents with generalized anxiety disorder

被引：0
|
作者：
Yeung, P
Kunz, N
Rynn, M
Riddle, M
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Johns Hopkins Univ, Baltimore, MD 21218 USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S194 / S195
页数：2
相关论文
共 50 条
  • [41] Prescriptive treatment for generalized anxiety disorder in children
    Eisen, AR
    Silverman, WK
    [J]. BEHAVIOR THERAPY, 1998, 29 (01) : 105 - 121
  • [42] Efficacy of venlafaxine and fluoxetine inpatients with major depressive disorder and co-morbid generalized anxiety disorder
    Silverstone, PH
    Salinas, EO
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S81 - S81
  • [43] Tolerability and efficacy of venlafaxine extended-release (ER) in patients with generalized anxiety disorder (GAD) experiencing severe gastrointestinal symptoms at baseline
    Lydiard, B
    Pitrosky, B
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S348 - S348
  • [44] Generalized anxiety disorder: Prevalence, predictors, and comorbidity in children and adolescents
    Mohammadi, Mohammad Reza
    Pourdehghan, Parandis
    Mostafavi, Seyed-Ali
    Hooshyari, Zahra
    Ahmadi, Nastaran
    Khaleghi, Ali
    [J]. JOURNAL OF ANXIETY DISORDERS, 2020, 73
  • [45] Efficacy and safety of atomoxetine in the treatment of attention deficit/hyperactivity disorder in children and adolescents
    Brown, WJ
    Biederman, J
    Spencer, T
    Heiligenstein, J
    Wernicke, J
    Allen, AJ
    Faries, D
    Michelson, D
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S411 - S411
  • [46] Efficacy and Safety of Atomoxetine in the Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder
    Kohn, Michael R.
    Tsang, Tracey W.
    Clarke, Simon D.
    [J]. CLINICAL MEDICINE INSIGHTS-PEDIATRICS, 2012, 6 : 95 - 162
  • [47] Venlafaxine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder
    Findling, Robert L.
    Greenhill, Laurence L.
    McNamara, Nora K.
    Demeter, Christine A.
    Kotler, Lisa A.
    O'Riordan, Mary Ann
    Myers, Carolyn
    Reed, Michael D.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (04) : 433 - 445
  • [48] Comorbidity of Attention Deficit Hyperactivity Disorder and Generalized Anxiety Disorder in children and adolescents
    Melegari, M. G.
    Bruni, O.
    Sacco, R.
    Barni, D.
    Sette, S.
    Donfrancesco, R.
    [J]. PSYCHIATRY RESEARCH, 2018, 270 : 780 - 785
  • [49] Improvement in functionality with treatment of generalized social anxiety disorder: Venlafaxine XR vs placebo
    Mallick, R
    Mangano, R
    Shrivastava, RK
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S356 - S357
  • [50] Comparative Study on the Efficacy and Safety of Tandospirone and Buspirone in the Treatment of Generalized Anxiety Disorder: A Clinical Analysis
    Chen, Yandan
    Cao, Wei
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 85 : 16 - 16
12345